Literature DB >> 23320617

Early stage phase separation in pharmaceutical solid dispersion thin films under high humidity: improved spatial understanding using probe-based thermal and spectroscopic nanocharacterization methods.

Sheng Qi1, Jonathan G Moffat, Ziyi Yang.   

Abstract

Phase separation in pharmaceutical solid dispersion thin films under high humidity is still poorly understood on the submicrometer scale. This study investigated the phase separation of a model solid dispersion thin film, felodipine-PVP K29/32, prepared by spin-coating and analyzed using probe-based methods including atomic force microscopy, nanothermal analysis, and photothermal infrared microspectroscopy. The combined use of these techniques revealed that the phase separation process occurring in the thin films under high humidity is different from that in dry conditions reported previously. The initial stage of phase separation is primarily initiated in the bulk of the films as amorphous drug domains. Drug migration toward the surface of the solid dispersion film was then observed to occur under exposure to increased humidity. PVP cannot prevent phase separation of felodipine under high humidity but can minimize the crystallization of amorphous felodipine domains in the solid dispersion thin films. This study demonstrates the unique abilities of these nanocharacterization methods for studying, in three dimensions, the phase separation of thin films for pharmaceutical applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23320617     DOI: 10.1021/mp300557q

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.

Authors:  Hitesh S Purohit; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-09-27       Impact factor: 4.200

2.  Combination of (M)DSC and surface analysis to study the phase behaviour and drug distribution of ternary solid dispersions.

Authors:  Joke Meeus; David J Scurr; Xinyong Chen; Katie Amssoms; Martyn C Davies; Clive J Roberts; Guy Van den Mooter
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

3.  Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.

Authors:  Ziyi Yang; Kathrin Nollenberger; Jessica Albers; Duncan Craig; Sheng Qi
Journal:  Pharm Res       Date:  2014-10-01       Impact factor: 4.200

Review 4.  Physical Stability of Amorphous Solid Dispersions: a Physicochemical Perspective with Thermodynamic, Kinetic and Environmental Aspects.

Authors:  Xia Lin; Yang Hu; Lei Liu; Lili Su; Na Li; Jing Yu; Bo Tang; Ziyi Yang
Journal:  Pharm Res       Date:  2018-04-23       Impact factor: 4.200

5.  The Physical Stability of Felodipine and Its Recrystallization from an Amorphous Solid Dispersion Studied by NMR Relaxometry.

Authors:  A Pajzderska; J Mielcarek; J Wąsicki
Journal:  AAPS PharmSciTech       Date:  2022-03-21       Impact factor: 3.246

6.  Spatial characterization of hot melt extruded dispersion systems using thermal atomic force microscopy methods: the effects of processing parameters on phase separation.

Authors:  Jonathan G Moffat; Sheng Qi; Duncan Q M Craig
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

Review 7.  Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.

Authors:  Arun Butreddy; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2020-11-28       Impact factor: 4.384

8.  Characterization of Heterogeneity and Spatial Distribution of Phases in Complex Solid Dispersions by Thermal Analysis by Structural Characterization and X-ray Micro Computed Tomography.

Authors:  Muqdad Alhijjaj; Samy Yassin; Mike Reading; J Axel Zeitler; Peter Belton; Sheng Qi
Journal:  Pharm Res       Date:  2016-04-19       Impact factor: 4.200

9.  Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.

Authors:  Na Li; Jonathan L Cape; Bharat R Mankani; Dmitry Y Zemlyanov; Kimberly B Shepard; Michael M Morgen; Lynne S Taylor
Journal:  Mol Pharm       Date:  2020-09-24       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.